Berger W, Spinas G A
Abteilung für Endokrinologie und Stoffwechsel, Kantonsspital Basel.
Ther Umsch. 1990 Jan;47(1):30-40.
In type 1 (insulin-dependent) diabetic patients, a good metabolic control can often be achieved only by means of an intensified insulin-giving regimen. This requires multiple insulin injections, whereby 60 to 70% of the total daily insulin amount are administered as preprandial boli of short or intermediate acting insulin. The remaining 30 to 40% of the daily insulin dosage are usually given as bedtime injection. With this form of therapy, sufficient metabolic control can be achieved in the majority of patients; however, due to the kinetics of subcutaneously injected insulin, there are some limitations to this therapeutic regimen. Physiological overnight insulin requirements, i.e. relatively small insulin requirement during the first part and increased insulin requirement during the second part of the night, are difficult to meet with currently available insulin preparations. It is, therefore, nearly impossible to achieve euglycemic fasting blood glucose levels without taking the risk of nocturnal hypoglycemia. Moreover, intensified insulin therapy requires regular selfmonitoring of blood glucose, and the patients have to stick to a quantitative diet and to a relatively fixed time schedule for meal ingestion. Several practical aspects as to the time and site of injection, postponing or "skipping" meals, etc., are discussed.
在1型(胰岛素依赖型)糖尿病患者中,通常只有通过强化胰岛素给药方案才能实现良好的代谢控制。这需要多次注射胰岛素,其中每日胰岛素总量的60%至70%作为短效或中效胰岛素的餐前提量给药。每日胰岛素剂量的其余30%至40%通常在睡前注射。通过这种治疗方式,大多数患者能够实现充分的代谢控制;然而,由于皮下注射胰岛素的动力学特性,这种治疗方案存在一些局限性。生理性夜间胰岛素需求,即在夜间前半段相对较小而在后半段增加的胰岛素需求,很难通过目前可用的胰岛素制剂来满足。因此,在不冒夜间低血糖风险的情况下,几乎不可能实现空腹血糖正常水平。此外,强化胰岛素治疗需要定期自我监测血糖,患者必须坚持定量饮食并遵循相对固定的进餐时间安排。文中还讨论了关于注射时间和部位、推迟或“跳过”进餐等几个实际问题。